The EIB supports research on vaccine to eradicate malaria

(Source: European Investment Bank)

The European Investment Bank and the European Commission were the early supporters of German BioNTech, the company which produced the first COVID-19 mRNA vaccine. BioNTech is now using its mRNA technology to develop a vaccine that could potentially eradicate malaria.

The EIB pledges to support them and other innovative companies in the fight against the disease. Working together for healthier lives!

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.